Eun-Hye Moon1, Yoo Sung Kim1, Jiyoung Seo1, Sabin Lee1, Young Jae Lee2, Suk Paul Oh3. 1. Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Republic of Korea. 2. Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Republic of Korea leeyj@gachon.ac.kr ohp@ufl.edu. 3. Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Republic of Korea Department of Physiology and Functional Genomics, College of Medicine, University of Florida, 1600 SW Archer Road, Room CG-20B, Gainesville, FL 32610, USA leeyj@gachon.ac.kr ohp@ufl.edu.
Abstract
AIMS: TMEM100 was previously identified as a downstream target of activin receptor-like kinase 1 (ALK1; ACVRL1) signalling. Mutations on ALK1 cause hereditary haemorrhagic telangiectasia (HHT), a vascular disorder characterized by mucocutaneous telangiectases and visceral arteriovenous malformations (AVMs). The aims of this study are to investigate the in vivo role of TMEM100 at various developmental and adult stages and to determine the extent to which TMEM100 contributed to the development of AVMs as a key downstream effector of ALK1. METHODS AND RESULTS: Blood vasculature in Tmem100-null embryos and inducible Tmem100-null neonatal and adult mice was examined. We found that TMEM100 deficiency resulted in cardiovascular defects at embryonic stage; dilated vessels, hyperbranching, and increased number of filopodia in the retinal vasculature at neonatal stage; and various vascular abnormalities, including internal haemorrhage, arteriovenous shunts, and weakening of vasculature with abnormal elastin layers at adult stage. However, arteriovenous shunts in adult mutant mice appeared to be underdeveloped without typical tortuosity of vessels associated with AVMs. We uncovered that the expression of genes encoding cell adhesion and extracellular matrix proteins was significantly affected in lungs of adult mutant mice. Especially Mfap4, which is associated with elastin fibre formation, was mostly down-regulated. CONCLUSION: These results demonstrate that TMEM100 has essential functions for the maintenance of vascular integrity as well as the formation of blood vessels. Our results also indicate that down-regulation of Tmem100 is not the central mechanism of HHT pathogenesis, but it may contribute to the development of vascular pathology of HHT by weakening vascular integrity. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: TMEM100 was previously identified as a downstream target of activin receptor-like kinase 1 (ALK1; ACVRL1) signalling. Mutations on ALK1 cause hereditary haemorrhagic telangiectasia (HHT), a vascular disorder characterized by mucocutaneous telangiectases and visceral arteriovenous malformations (AVMs). The aims of this study are to investigate the in vivo role of TMEM100 at various developmental and adult stages and to determine the extent to which TMEM100 contributed to the development of AVMs as a key downstream effector of ALK1. METHODS AND RESULTS: Blood vasculature in Tmem100-null embryos and inducible Tmem100-null neonatal and adult mice was examined. We found that TMEM100 deficiency resulted in cardiovascular defects at embryonic stage; dilated vessels, hyperbranching, and increased number of filopodia in the retinal vasculature at neonatal stage; and various vascular abnormalities, including internal haemorrhage, arteriovenous shunts, and weakening of vasculature with abnormal elastin layers at adult stage. However, arteriovenous shunts in adult mutant mice appeared to be underdeveloped without typical tortuosity of vessels associated with AVMs. We uncovered that the expression of genes encoding cell adhesion and extracellular matrix proteins was significantly affected in lungs of adult mutant mice. Especially Mfap4, which is associated with elastin fibre formation, was mostly down-regulated. CONCLUSION: These results demonstrate that TMEM100 has essential functions for the maintenance of vascular integrity as well as the formation of blood vessels. Our results also indicate that down-regulation of Tmem100 is not the central mechanism of HHT pathogenesis, but it may contribute to the development of vascular pathology of HHT by weakening vascular integrity. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith Journal: Invest Ophthalmol Vis Sci Date: 2010-06 Impact factor: 4.799
Authors: Evelyn Torsney; Richard Charlton; Austin G Diamond; John Burn; James V Soames; Helen M Arthur Journal: Circulation Date: 2003-03-17 Impact factor: 29.690
Authors: A Schlosser; T Thomsen; J M Shipley; P W Hein; F Brasch; I Tornøe; O Nielsen; K Skjødt; N Palaniyar; W Steinhilber; F X McCormack; U Holmskov Journal: Scand J Immunol Date: 2006-08 Impact factor: 3.487
Authors: Jeong-Hoon Joo; Young Jae Lee; Gustavo C Munguba; Sean Park; Timothy J Taxter; Mohamed Y Elsagga; Moira R Jackson; S Paul Oh; Stephen P Sugrue Journal: Dev Dyn Date: 2007-08 Impact factor: 3.780
Authors: Simon Tual-Chalot; Marwa Mahmoud; Kathleen R Allinson; Rachael E Redgrave; Zhenhua Zhai; S Paul Oh; Marcus Fruttiger; Helen M Arthur Journal: PLoS One Date: 2014-06-04 Impact factor: 3.240
Authors: Xueyu Chen; Mar Orriols; Frans J Walther; El Houari Laghmani; Annemarie M Hoogeboom; Anne C B Hogen-Esch; Pieter S Hiemstra; Gert Folkerts; Marie-José T H Goumans; Peter Ten Dijke; Nicholas W Morrell; Gerry T M Wagenaar Journal: Front Physiol Date: 2017-07-13 Impact factor: 4.566